Compliance in epileptology: a modern view of the problem and strategies for its optimization
https://doi.org/10.17749/2077-8333.2020.12.1.74-81
Abstract
Low adherence to therapy in patients with epilepsy is today a serious problem, despite the emergence of new opportunities for the treatment of seizures. According to modern data, the level of non-adherence is 29–39%. Non-adherence is naturally associated with adverse clinical outcomes, such as status epilepticus and sudden death syndrome, which generally increase the risk of death. Thus, the study of the causes of low adherence in patients with epilepsy is necessary for doctors to develop strategies to increase it.
About the Authors
N. N. Maslova
Smolensk State Medical University
Russian Federation
Russian Federation
MD, Dr Sci Med, Professor, Headof the Department of Neurology and Neurosurgery,
Krupskaya Str., 28, Smolensk 214019, Smolensk Region, Russia
V. A. Skorobogatova
Smolensk State Medical University
Russian Federation
Russian Federation
Clinical Resident of the Department of Neurology and Neurosurgery,
Krupskaya Str., 28, Smolensk 214019, Smolensk Region, Russia
References
1. Hovinga C.A., Asato M.R, Manjunath R., et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy and Behavior. 2008; 13(2): 16-22.
2. Karlov V. A. Epilepsy in children and adult women and men. A guide for doctors. Second edition. Moscow. 2019; 896 p.
3. Garnett WR. Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy. 2000; 20:191S-9S.
4. Ramon Edmundo D. Bautista. Understanding the self-management skills of persons with epilepsy. Epilepsy and Behavior. 2017; V. 69.
5. Kobau R., DiIorio C. Epilepsy self-management: a comparison of self-efficacy and outcome expectancy for medication adherence and lifestyle behaviors among people with epilepsy. Epilepsy and Behavior. 2003; 4:217–25.
6. Dilorio C., Shafer PO, Letz R, Henry TR, Schomer DL, Yeager K. Behavioral, social, and affective factors associated with selfefficacy for self-management among people with epilepsy. Epilepsy and Behavior. 2006; 9:158–63.
7. Badawy R.A., Curatolo JM, Newton M, Berkovic SF, Macdonell RA. Sleep deprivation increases cortical excitability in epilepsy: syndrome-specific effects. Neurology. 2006; 67:1018–22.
8. Grenard J.L., Munjas B.A, Adams J.L., Suttorp M., Maglione M., McGlynn E.A., et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a metaanalysis. J Gen Intern Med. 2011; 26:1175–82.
9. Ettinger A.B., Good M.B., Manjunath R., Faught E.R., Bancroft T. The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy. Epilepsy and Behavior. 2014; 36:138–43.
10. Guo Y., Xiao-Yan D., Ru-Yi L., Chun-Hong S., Yao D., Shuang W., et al. Depression and anxiety are associated with reduced antiepileptic drug adherence in Chinese patients. Epilepsy and Behavior. 2015 50:91–5.
11. O’Rourke G., O’Brien J.J. Identifying the barriers to antiepileptic drug adherence among adults with epilepsy. Seizure. 2017; 45: 160–168.
12. Hesdorffer D.C., Ishihara L., Mynepalli L., Webb D.J., Weil J., Hauser W.A. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurology. 2012; 72:184–191.
13. Tang F., Zhu G., Jiao Z., Ma C., Wang B.. Self-reported adherence in patients with epilepsy who missed their medications and reasons for nonadherence in China. Epilepsy and Behavior. 2013; 27(1):85–9.
14. Ferrari C.M.M., Cardosa de Sousa R.M., Castro L.H.M. Factors associated with treatment non-adherence in patients with epilepsy. Seizurе. 2013; 27(3):384-9.
15. Chapman S.C.E., Horne R., Chater A., Hukins D., Smithson W.H. Patients perspectives on antiepileptic medication: relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care. Epilepsy and Behavior. 2014; 31(4):312–20.
16. Devinsky O. Recognizing and preventing epilepsy-related mortality. Neurology. 2016; 86:779–786.
17. Friedman D., Donner E.J., Stephens D., Wright C., Devinsky O. Sudden unexpected death in epilepsy: knowledge and experience among U.S. and Canadian neurologists. Epilepsy and Behavior. 2014; 35:13–18.
18. Miller WR, Young N, Friedman D, Buelow JM, Devinsky O. Discussing sudden unexpected death in epilepsy (SUDEP) with patients: practices of health-care providers. Epilepsy and Behavior. 2014; 32:38–41.
19. Sillanpaa M., Shinnar S. Long-term mortality in childhood-onset epilepsy. N Engl J Med. 2010; 363: 2522–2529.
20. Nashef L., So E.L., Ryvlin P., Tomson T. Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia. 2012; 53:227–233.
21. Lamberts R.J., Blom M.T., Wassenaar M., et al. Sudden cardiac arrest in people with epilepsy in the community: circumstances and risk factors. Neurology. 2015; 85:212–218.
22. Faught E., Richman J., Martin R., et al. Incidence and prevalence of epilepsy among older U. S. Medicare beneficiaries. Neurology. 2012; 78:448–453.
23. Avakyan G.N., Belousova E.D., Burd S.G., Vlasov P.N., Ermolenko N.A., Kissin M.Y., Lebedeva A.V., Lipatova L.V., Kiteva-Trenchevska G. Current trends in epileptology: priorities, challenges, tasks and solutions. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2019;11(4):395-406. (In Russ.) DOI: https://doi.org/10.17749/2077-8333.2019.11.4.395-406.
Review
For citations:
Maslova N.N., Skorobogatova V.A. Compliance in epileptology: a modern view of the problem and strategies for its optimization. Epilepsy and paroxysmal conditions. 2020;12(1):74-81. (In Russ.) https://doi.org/10.17749/2077-8333.2020.12.1.74-81
Views: 801
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
